HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin.

AbstractOBJECTIVE:
To report the successful treatment of vancomycin-resistant Enterococcus (VRE) bacteremia using the combination of quinupristin/dalfopristin and high-dose ampicillin.
CASE SUMMARY:
A 38-year-old African American woman with relapsed acute myeloid leukemia and neutropenic fever developed VRE bacteremia following 3 successive courses of vancomycin for methicillin-resistant staphylococcal infections. Treatment with linezolid was initiated; however, after 9 days of therapy, blood cultures continued to reveal VRE and the patient became febrile. The patient was subsequently switched to quinupristin/dalfopristin and high-dose ampicillin. The fever resolved and all subsequent blood cultures were negative after the initiation of combination therapy.
DISCUSSION:
The emergence of VRE infections presents a treatment challenge in immunocompromised patients. When treating VRE infections in this patient population, the effectiveness of linezolid and quinupristin/dalfopristin is limited by their bacteriostatic activity when used as monotherapy. Recent in vitro data suggest synergistic activity with quinupristin/dalfopristin when used in combination with other antimicrobials in selected isolates of VRE.
CONCLUSIONS:
Persistent VRE bacteremia was successfully treated in this neutropenic patient using the combination of high-dose ampicillin and quinupristin/dalfopristin. Case reports and in vitro data suggest that concomitant therapy with high-dose ampicillin may be an effective treatment alternative for VRE infections not responding to standard therapy.
AuthorsJ Audis Bethea, Christine M Walko, Patricia A Targos
JournalThe Annals of pharmacotherapy (Ann Pharmacother) Vol. 38 Issue 6 Pg. 989-91 (Jun 2004) ISSN: 1060-0280 [Print] United States
PMID15100393 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Virginiamycin
  • quinupristin-dalfopristin
  • Ampicillin
Topics
  • Adult
  • Ampicillin (administration & dosage, therapeutic use)
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Bacteremia (complications, drug therapy, microbiology)
  • Drug Therapy, Combination
  • Enterococcus faecium
  • Female
  • Humans
  • Leukemia, Myeloid, Acute (complications, drug therapy)
  • Neutropenia (complications)
  • Staphylococcal Infections (complications, drug therapy)
  • Vancomycin Resistance
  • Virginiamycin (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: